Puma Biotechnology
PBYI
PBYI
121 hedge funds and large institutions have $112M invested in Puma Biotechnology in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.74% more ownership
Funds ownership: 61.31% → 66.05% (+4.7%)
4% more funds holding
Funds holding: 116 → 121 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
121
Holding in Top 10
1
Calls
$330K
Puts
$4K
Top Buyers
| 1 | +$2.56M | |
| 2 | +$1.74M | |
| 3 | +$1.65M | |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$1.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$896K |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$490K | |
| 3 | -$316K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$294K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$245K |
